FI47100C - Menetelmä terapeuttisesti vaikuttavien 1-p-klooribentsoyyli-2-alempi-a lkyyli-5-alempi-alkoksi-3-indolyyli-etikkahapon valmistamiseksi. - Google Patents

Menetelmä terapeuttisesti vaikuttavien 1-p-klooribentsoyyli-2-alempi-a lkyyli-5-alempi-alkoksi-3-indolyyli-etikkahapon valmistamiseksi.

Info

Publication number
FI47100C
FI47100C FI257470A FI257470A FI47100C FI 47100 C FI47100 C FI 47100C FI 257470 A FI257470 A FI 257470A FI 257470 A FI257470 A FI 257470A FI 47100 C FI47100 C FI 47100C
Authority
FI
Finland
Prior art keywords
chlorobenzoyl
indolyl
alkoxy
alkyl
preparation
Prior art date
Application number
FI257470A
Other languages
English (en)
Swedish (sv)
Other versions
FI47100B (fi
Inventor
George Gal
Sletzinger
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI47100B publication Critical patent/FI47100B/fi
Application granted granted Critical
Publication of FI47100C publication Critical patent/FI47100C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/281-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/36Oxygen atoms in position 3, e.g. adrenochrome

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI257470A 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavien 1-p-klooribentsoyyli-2-alempi-a lkyyli-5-alempi-alkoksi-3-indolyyli-etikkahapon valmistamiseksi. FI47100C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25564263A 1963-02-01 1963-02-01

Publications (2)

Publication Number Publication Date
FI47100B FI47100B (fi) 1973-05-31
FI47100C true FI47100C (fi) 1973-09-10

Family

ID=22969254

Family Applications (9)

Application Number Title Priority Date Filing Date
FI16964A FI46955C (fi) 1963-02-01 1964-01-29 Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-alempi-al kyyli-5-alempi-alkoksi-3-indolyyli-etikkahapon valmistamiseksi
FI257370A FI47185C (fi) 1963-02-01 1970-09-21 Menetelmä 1-p-klooribentsoyyli-2-metyyli-5-metoksi-indoli-3-etanolin v almistamiseksi, jolla on tulehdusta estävä, antipyreettinen ja anlgeet tinen vaikutus.
FI257270A FI47099C (fi) 1963-02-01 1970-09-21 Menetelmä 1-p-klooribentsoyyli-2-metyyli-5-metoksi-3-indolyylietikkaha pon valmistamiseksi, jolla on tulehdusta estävä, antipyreettinen ja an algeettinen vaikutus.
FI257170A FI47098C (fi) 1963-02-01 1970-09-21 Menetelmä 1-p-klooribentsoyyli-2-metyyli-5-metoksi-3-indolyyliasetalde hydin valmistamiseksi, jolla on tulehdusta estävä, antipyreettinen ja analgeettinen vaikutus.
FI257470A FI47100C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavien 1-p-klooribentsoyyli-2-alempi-a lkyyli-5-alempi-alkoksi-3-indolyyli-etikkahapon valmistamiseksi.
FI702570A FI47097C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-metyyli-5 -metoksi-3-indolyylietikkahapon valmistamiseksi.
FI257570A FI47101C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavien alfa-(3-indolyyli)-alempien-ali faattisten happojen valmistamiseksi.
FI257070A FI47097B (fi) 1963-02-01 1970-09-21
FI256870A FI47096C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavien alfa-(3-indolyyli)-alempien-ali faattisten happojen tert.-butyyliesterin valmistamiseksi.

Family Applications Before (4)

Application Number Title Priority Date Filing Date
FI16964A FI46955C (fi) 1963-02-01 1964-01-29 Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-alempi-al kyyli-5-alempi-alkoksi-3-indolyyli-etikkahapon valmistamiseksi
FI257370A FI47185C (fi) 1963-02-01 1970-09-21 Menetelmä 1-p-klooribentsoyyli-2-metyyli-5-metoksi-indoli-3-etanolin v almistamiseksi, jolla on tulehdusta estävä, antipyreettinen ja anlgeet tinen vaikutus.
FI257270A FI47099C (fi) 1963-02-01 1970-09-21 Menetelmä 1-p-klooribentsoyyli-2-metyyli-5-metoksi-3-indolyylietikkaha pon valmistamiseksi, jolla on tulehdusta estävä, antipyreettinen ja an algeettinen vaikutus.
FI257170A FI47098C (fi) 1963-02-01 1970-09-21 Menetelmä 1-p-klooribentsoyyli-2-metyyli-5-metoksi-3-indolyyliasetalde hydin valmistamiseksi, jolla on tulehdusta estävä, antipyreettinen ja analgeettinen vaikutus.

Family Applications After (4)

Application Number Title Priority Date Filing Date
FI702570A FI47097C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-metyyli-5 -metoksi-3-indolyylietikkahapon valmistamiseksi.
FI257570A FI47101C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavien alfa-(3-indolyyli)-alempien-ali faattisten happojen valmistamiseksi.
FI257070A FI47097B (fi) 1963-02-01 1970-09-21
FI256870A FI47096C (fi) 1963-02-01 1970-09-21 Menetelmä terapeuttisesti vaikuttavien alfa-(3-indolyyli)-alempien-ali faattisten happojen tert.-butyyliesterin valmistamiseksi.

Country Status (11)

Country Link
AT (1) AT277992B (fi)
BE (1) BE643268A (fi)
BR (1) BR6456479D0 (fi)
CH (16) CH466286A (fi)
DE (16) DE1695492A1 (fi)
DK (11) DK109334C (fi)
FI (9) FI46955C (fi)
FR (1) FR1559559A (fi)
GB (13) GB1050736A (fi)
NL (1) NL6400813A (fi)
SE (12) SE317975B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU163233B (fi) * 1970-07-31 1973-07-28
DE58902127D1 (de) * 1988-06-21 1992-10-01 Rauter Vita Zahnfabrik Dispergierte keramikmasse.
GB9518994D0 (en) * 1995-09-16 1995-11-15 Agrevo Uk Ltd Fungicides

Also Published As

Publication number Publication date
CH457434A (de) 1968-06-15
DE1793561A1 (de) 1972-01-20
SE302133B (sv) 1968-07-08
GB1050739A (fi)
DE1695484A1 (de) 1971-04-15
CH489495A (de) 1970-04-30
CH466284A (de) 1968-12-15
GB1050737A (fi)
DE1695485A1 (de) 1971-04-15
FI46955B (fi) 1973-05-02
CH466287A (de) 1968-12-15
CH466286A (de) 1968-12-15
FI47096B (fi) 1973-05-31
FR1559559A (fi) 1969-03-14
SE320367B (fi) 1970-02-09
AT277992B (de) 1970-01-12
DE1695493A1 (de) 1971-04-01
FI47098B (fi) 1973-05-31
DE1695488A1 (de) 1970-09-17
FI47100B (fi) 1973-05-31
CH466289A (de) 1968-12-15
DE1770132A1 (de) 1971-09-30
GB1050730A (fi)
DK109514C (da) 1968-05-06
DK109562C (da) 1968-05-13
GB1050728A (fi)
FI47101C (fi) 1973-09-10
CH457436A (de) 1968-06-15
GB1050738A (fi)
SE302463B (fi) 1968-07-22
CH464203A (de) 1968-10-31
GB1050731A (fi)
DK112239B (da) 1968-11-25
SE320666B (fi) 1970-02-16
FI47098C (fi) 1973-09-10
SE302130B (sv) 1968-07-08
DK112313B (da) 1968-12-02
CH457435A (de) 1968-06-15
NL6400813A (fi) 1964-08-03
FI46955C (fi) 1973-08-10
GB1050732A (fi)
CH466283A (de) 1968-12-15
DK112238B (da) 1968-11-25
SE304995B (fi) 1968-10-14
DK112447B (da) 1968-12-16
DE1695489A1 (de) 1970-08-13
FI47097B (fi) 1973-05-31
SE307948B (fi) 1969-01-27
SE307133B (fi) 1968-12-23
SE320069B (fi) 1970-02-02
DK112446B (da) 1968-12-16
DE1695490A1 (de) 1971-04-15
SE317975B (fi) 1969-12-01
CH466290A (de) 1968-12-15
CH457437A (de) 1968-06-15
CH557815A (de) 1975-01-15
DE1695487A1 (de) 1970-10-01
GB1050733A (fi)
GB1050740A (fi)
FI47096C (fi) 1973-09-10
SE302132B (sv) 1968-07-08
DK112314B (da) 1968-12-02
FI47185B (fi) 1973-07-02
FI47097C (fi) 1973-09-10
DE1695486A1 (de) 1971-04-15
CH466288A (de) 1968-12-15
GB1050736A (fi)
DE1695491A1 (de) 1971-04-15
GB1050735A (fi)
BR6456479D0 (pt) 1973-09-20
DK109334C (da) 1968-04-16
DE1695492A1 (de) 1971-04-01
FI47101B (fi) 1973-05-31
DK111751B (da) 1968-10-07
CH466285A (de) 1968-12-15
FI47099B (fi) 1973-05-31
GB1050729A (fi)
DE1770802A1 (de) 1972-02-17
BE643268A (fi) 1964-07-31
FI47099C (fi) 1973-09-10
SE302131B (fi) 1968-07-08
DE1770134A1 (de) 1971-09-30
GB1050734A (fi)
FI47185C (fi) 1973-10-10
DE1770116A1 (de) 1971-10-14
DK113501B (da) 1969-03-31
CH464202A (de) 1968-10-31
DE1470059B1 (de) 1970-01-29

Similar Documents

Publication Publication Date Title
FI42712C (fi) Menetelmä terapeuttisesti vaikuttavien bifenyylialkaanijohdannaisten valmistamiseksi
FI48590C (fi) Menetelmä terapeuttisesti käytettävien atsaspiroalkaanidioniyhdisteide n valmistamiseksi.
FI51046C (fi) Menetelmä asetosalisyylihappotabletin valmistamiseksi.
FI49497C (fi) Menetelmä terapeuttisesti vaikuttavien 1-fenoksi-2-3-alkyyliaminopropa anien valmistamiseksi.
DK133372B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive hydroxy-cyclohexyl-aminer eller syreadditionssalte deraf.
FI49720C (fi) Menetelmä terapeuttisesti vaikuttavien 2-metyyli-3-karbonihappoamidoki noksaliini-di-N-oksidien-(1,4) valmistamiseksi.
FI46848C (fi) Menetelmä terapeuttisesti vaikuttavien 3-halogeeni-3H-1,2-dihydro-1,4- bentsodiatsepiini-2-onien valmistamiseksi.
FI47365C (fi) Menetelmä valmistaa uusia terapeuttisesti vaikuttavia indolijohdannais ia.
FI52857C (fi) Menetelmä terapeuttisesti vaikuttavien amidoksiimien valmistamiseksi.
FI46501C (fi) Menetelmä terapeuttisesti aktiivisten, substituoitujen fenyylietikkaha ppoestereiden valmistamiseksi.
FI45041C (fi) Menetelmä terapeuttisesti käyttökelpoisten pyrroli-johdannaisten valmi stamiseksi.
FI45180C (fi) Menetelmä terapeuttisesti arvokkaiden sulfonanilidien valmistamiseksi.
FI45551C (fi) Menetelmä terapeuttisesti käytettävän dehydroepiandrosteroniönantaatin valmistamiseksi.
FI46961C (fi) Menetelmä terapeuttisesti aktiivisten 5-nitroimidatsolikarbamaattien v almistamiseksi
NL140236B (nl) Werkwijze ter bereiding van farmacologisch werkzame sulfamylantranilzuurderivaten.
FI49718C (fi) Menetelmä terapeuttisesti vaikuttavien 2-halogeenimetyyli-3-karbonihap poamidokinoksaliini-di-N-oksidien-(1,4) valmistamiseksi.
FI47881C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen fenyyliasetamidi en valmistamiseksi
FI49032C (fi) Menetelmä terapeuttisesti aktiivisten 7-nitro-8-hydroksi-kinoliini-est erien valmistamiseksi.
FI47100C (fi) Menetelmä terapeuttisesti vaikuttavien 1-p-klooribentsoyyli-2-alempi-a lkyyli-5-alempi-alkoksi-3-indolyyli-etikkahapon valmistamiseksi.
FI47189C (fi) Tapa valmistaa terapeuttisesti vaikuttavia d-lysergiinihappo-N-fenyyli piperatsideja.
FI48576C (fi) Menetelmä terapeuttisesti aktiivisten alfa-fluori-malonihappojohdannai sten valmistamiseksi.
FI45043C (fi) Menetelmä terapeuttisesti vaikuttavien, substituoitujen butynyyli-suks iini-imidien ja -glutaari-imidien valmistamiseksi.
FI45954C (fi) Menetelmä terapeuttisesti vaikuttavien bentseenisulfonyylivirtsa-ainei den valmistamiseksi.
FI50879C (fi) Menetelmä terapeuttisesti vaikuttavien substituoitujen 3-aminoasyyliam ino-tiofeenien valmistamiseksi.
FI45045C (fi) Menetelmä uusien terapeuttisesti vaikuttavien 5-nitro-2-furyyli-isoksa tsolijohdannaisten valmistamiseksi.